Cat. #152626
Anti-CD90 [T11D7e]
Cat. #: 152626
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: CD90, Thy1.1
Class: Monoclonal
Application: FACS ; Fn
Reactivity: Mouse ; Rat
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Phil Lake
Institute: University College London (UCL)
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-CD90 [T11D7e]
- Alternate name: Thy-1 Cell Surface Antigen; Thy-1 Antigen; CDw9; CD9
- Clone: T11D7e
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: Mouse ; Rat
- Host: Mouse
- Application: FACS ; Fn
- Description: CD90 (Thy1.1) is a monomorphic determinant in rat but polymorphic in mice. Anti-CD90 [T11D7e] reacts with Thy1.1 mice e.g. AKR and FVB mice, but not Thy1.2 mice such as CBA and BALB/c. Clone T11D7e is useful for removal of T lymphocytes from cell populations by complement mediated cytotoxicity. CD90 is a mesenchymal cell marker
- Immunogen: Xenogenic rat thymocytes
- Isotype: IgM
- Myeloma used: P3/NS1/1-Ag4.1
- Recommended controls: Mouse thymocytes
Target Details
- Target: CD90, Thy1.1
- Tissue cell line specificity: Mouse thymocytes
- Target background: CD90 (Thy1.1) is a monomorphic determinant in rat but polymorphic in mice. Anti-CD90 [T11D7e] reacts with Thy1.1 mice e.g. AKR and FVB mice, but not Thy1.2 mice such as CBA and BALB/c. Clone T11D7e is useful for removal of T lymphocytes from cell populations by complement mediated cytotoxicity. CD90 is a mesenchymal cell marker
Applications
- Application: FACS ; Fn
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
Related Tools
- Related tools: Anti-CD90 [T11D7] ; Anti-CD90 [T11D7e2]
References
- Mahanthappa et al. 1996. J Neurosci. 16(15):4673-83. PMID: 8764655.
- Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth.
- Ogasawara et al. 1990. Microbiol Immunol. 34(12):1025-39. PMID: 2098631.
- Fabian et al. 1990. Neurology. 40(3 Pt 1):419-22. PMID: 1690363.
- Uptake of antineuronal IgM by CNS neurons: comparison with antineuronal IgG.
- Ia restriction specificity of KLH-specific T cells from allogeneic bone marrow chimeras is influenced by histocompatibility at the H-2 and minor histocompatibility loci.
- Yasumizu et al. 1988. J Immunol. 141(6):2181-6. PMID: 3049801.
- Development of donor-derived thymic lymphomas after allogeneic bone marrow transplantation in AKR/J mice.
- Lake et al. 1979. Eur J Immunol. 9(11):875-86. PMID: 393521.
- Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets.
